Scrapie Infection in Experimental Rodents and SMB-S15 Cells Decreased the Brain Endogenous Levels and Activities of Sirt1

详细信息    查看全文

• 作者：Jing Wang ; Jin Zhang ; Qi Shi ; Bao-Yun Zhang ; Cao Chen…
• 关键词：Prion ; Scrapie ; Sirt1 ; Acetylation ; Resveratrol
• 刊名：Journal of Molecular Neuroscience
• 出版年：2015
• 出版时间：April 2015
• 年：2015
• 卷：55
• 期：4
• 页码：1022-1030
• 全文大小：3,445 KB
• 参考文献：1. Aguzzi, A (2006) Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis. J Neurochem 97: pp. 1726-1739 CrossRef
  2. Albani, D, Polito, L, Signorini, A, Forloni, G (2010) Neuroprotective properties of resveratrol in different neurodegenerative disorders. Biofactors 36: pp. 370-376 CrossRef
  3. Bizat, N, Peyrin, JM, Haik, S (2010) Neuron dysfunction is induced by prion protein with an insertional mutation via a Fyn kinase and reversed by sirtuin activation in Caenorhabditis elegans. J Neurosci 30: pp. 5394-5403 CrossRef
  4. Chen, D, Steele, AD, Hutter, G (2008) The role of calorie restriction and SIRT1 in prion-mediated neurodegeneration. Exp Gerontol 43: pp. 1086-1093 CrossRef
  5. Donmez, G (2013) Sirtuins as possible targets in neurodegenerative diseases. Curr Drug Targets 14: pp. 644-647 CrossRef
  6. Donmez, G, Outeiro, TF (2013) SIRT1 and SIRT2: emerging targets in neurodegeneration. EMBO Mol Med 5: pp. 344-352 CrossRef
  7. Donmez, G, Wang, D, Cohen, DE, Guarente, L (2010) SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 142: pp. 320-332 CrossRef
  8. Donmez, G, Arun, A, Chung, CY, McLean, PJ, Lindquist, S, Guarente, L (2012) SIRT1 protects against alpha-synuclein aggregation by activating molecular chaperones. J Neurosci 32: pp. 124-132 CrossRef
  9. Duan, W (2013) Sirtuins: from metabolic regulation to brain aging. Front Aging Neurosci 5: pp. 36 CrossRef
  10. Haig, DA, Clarke, MC (1971) Multiplication of the scrapie agent. Nature 234: pp. 106-107 CrossRef
  11. Ho, DJ, Calingasan, NY, Wille, E, Dumont, M, Beal, MF (2010) Resveratrol protects against peripheral deficits in a mouse model of Huntington’s disease. Exp Neurol 225: pp. 74-84 CrossRef
  12. Jeong, JK, Moon, MH, Lee, YJ, Seol, JW, Park, SY (2013) Autophagy induced by the class III histone deacetylase Sirt1 prevents prion peptide neurotoxicity. Neurobiol Aging 34: pp. 146-156 CrossRef
  13. Khan, RS, Fonseca-Kelly, Z, Callinan, C, Zuo, L, Sachdeva, MM, Shindler, KS (2012) SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells. Front Cell Neurosci 6: pp. 63 CrossRef
  14. Kretzschmar, HA (1999) Molecular pathogenesis of prion diseases. Eur Arch Psychiatry Clin Neurosci 249: pp. 56-63 CrossRef
  15. Luo, J, Nikolaev, AY, Imai, S (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107: pp. 137-148 CrossRef
  16. Mattson, MP, Magnus, T (2006) Ageing and neuronal vulnerability. Nat Rev Neurosci 7: pp. 278-294 CrossRef
  17. Milne, JC, Lambert, PD, Schenk, S (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450: pp. 712-716 CrossRef
  18. Min, SW, Cho, SH, Zhou, Y (2010) Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 67: pp. 953-966 <
• 刊物主题：Neurosciences; Neurochemistry; Cell Biology; Proteomics; Neurology;
• 出版者：Springer US
• ISSN：1559-1166

文摘

Prion diseases are composed of a group of fatal neurodegenerative disorders resulting from misfolding of cellular prion (PrPC) into scrapie prion (PrPSc). Sirt1, a class III histone deacetylase, has been reported to protect neuronal cells against PrP (106-26)-induced cell death. To address the potential role of Sirt1 during prion infection, the levels and enzyme activities of Sirt1 in the brains of scrapie-infected rodents, including hamsters infected with strain 263K, mice infected with strains 139A and ME7, and in prion infected SMB-S15 cells, were analyzed. Western blots revealed that endogenous Sirt1 levels were significantly decreased in all tested scrapie-infected models. Dynamic assays of brain Sirt1 levels in 263K-infected hamsters during incubation period showed a time-dependent decrease. The acetylating forms of Sirt1 target proteins, P53, PGC-1, and STAT3, markedly increased both in the brains of scrapie-infected rodents and in SMB-S15 cells, representing decreased Sirt1 activity. Immunofluorescent assays illustrated that Sirt1 predominately localized in cytosol of SMB-S15 cells but clearly distributed in nucleus of its normal partner cell line, SMB-PS. Moreover, accompanying with increase of Sirt1 level and decrease of acetyl-P53 level, treatments with Sirt1 activators SRT1720 and resveratrol in SMB-S15 cells significantly reduced PrPSc; at the same time, the cellular distribution of PrP proteins became normal, and the cell proliferating state was slightly improved. These data indicate that prion infection notably attenuates the Sirt1 activity in host cells. Sensitivity of the PrPSc to Sirt1 activators highlights a potential role of Sirt1 in prion therapeutics.